1370409-28-1 Usage
General Description
Saxagliptin hydrochloride monohydrate is a medication used to treat type 2 diabetes. It belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by helping the body to make more insulin and lower blood sugar levels. This chemical compound is a white to off-white, non-hygroscopic, crystalline powder that is soluble in water and methanol. It is commonly used in combination with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Common side effects may include headache, urinary tract infections, and upper respiratory infections. However, it may also have more serious side effects such as pancreatitis and allergic reactions, so it should be used cautiously under the guidance of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 1370409-28-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,0,4,0 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1370409-28:
(9*1)+(8*3)+(7*7)+(6*0)+(5*4)+(4*0)+(3*9)+(2*2)+(1*8)=141
141 % 10 = 1
So 1370409-28-1 is a valid CAS Registry Number.
1370409-28-1Relevant articles and documents
CRYSTAL FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING SAME
-
Page/Page column 32, (2008/12/08)
Physical crystal structures of a compound of the formula (I): are provided including the free base monohydrate thereof (form H-1) and the hydrochloric acid salt thereof, including hydrochloric acid salt containing 0.75 equivalent of H2O (form H0.75-3) and hydrochloric acid salt containing 2 equivalents of H2O (form H2-1), and hydrochloric acid salt Pattern P-5, preferably in substantially pure form, and other forms as described herein, pharmaceutical compositions containing structures of compound I or IA, processes for preparing same, intermediates used in preparing same, and methods of treating diseases such as diabetes using such structures.
